Epidermal Growth Factor Receptor-mediated Tissue Transglutaminase Overexpression Couples Acquired Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance and Migration through c-FLIP and MMP-9 Proteins in Lung Cancer Cells
Authors:
Open Access
- 1 June 2011
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (24) , 21164-21172
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Anti-Apoptotic Mechanisms of Drug Resistance in CancerCurrent Cancer Drug Targets, 2009
- Acquired resistance to TRAIL-induced apoptosis in human ovarian cancer cells is conferred by increased turnover of mature caspase-3Molecular Cancer Therapeutics, 2006
- Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Tumor therapeutics by design: targeting and activation of death receptorsCytokine & Growth Factor Reviews, 2005
- Mechanisms of resistance to TRAIL-induced apoptosis in cancerCancer Gene Therapy, 2004
- TRAIL and NFκB Signaling—a Complex Relationship2004
- Tissue Transglutaminase Directly Regulates Adenylyl Cyclase Resulting in Enhanced cAMP-response Element-binding Protein (CREB) ActivationJournal of Biological Chemistry, 2003
- Transglutaminases: crosslinking enzymes with pleiotropic functionsNature Reviews Molecular Cell Biology, 2003
- Matrix Metalloproteinases in Lung DiseasesCurrent Protein & Peptide Science, 2002
- The Death Domain Kinase RIP Is Essential for TRAIL (Apo2L)-Induced Activation of IκB Kinase and c-Jun N-Terminal KinaseMolecular and Cellular Biology, 2000